Evaluation of Different Ion-Pairing Reagents for LC/UV and LC/MS Analysis of Oligonucleotides
Applications | 2021 | Agilent TechnologiesInstrumentation
The reliable analysis of synthetic oligonucleotides underpins the development, quality assurance, and therapeutic application of modern nucleic acid drugs. Ion-pair liquid chromatography coupled with UV or mass spectrometric detection is widely used to separate and characterize oligonucleotide products, identify process-related impurities, and support sequence confirmation. Optimizing mobile phase additives enhances separation efficiency, detection sensitivity, and reduces analysis cost.
This work evaluates the impact of various ion-pairing reagents—triethylamine, n-butylamine, dibutylamine, and hexylamine—combined with acetate or hexafluoroisopropanol (HFIP) counterions on reversed-phase LC/UV and LC/MS performance for oligonucleotides. Chromatographic retention, resolution, mass spectral quality, charge-state distribution, and adduct formation were compared using DNA and RNA ladder standards as well as therapeutic oligonucleotides.
Experimental conditions included an Agilent AdvanceBio oligonucleotide column (2.1×50 mm, 2.7 µm) on an Agilent 1290 Infinity II LC system with diode-array detection and an Agilent 6530 LC/Q-TOF MS with Jet Stream ESI. Mobile phases comprised equimolar amine/acetic acid buffers (100 mM) or mixtures of 15 mM amine with HFIP (25–400 mM) in water, eluted with shallow gradients of acetonitrile or methanol at 65 °C.
Optimized ion-pair reagent selection allows tailored separations for diverse oligonucleotide chemistries, improves impurity resolution, and boosts MS detection while lowering consumable usage. Reduced adduct formation enhances confidence in mass assignments, supporting robust sequence verification and impurity profiling in QA/QC and research environments.
Advances may include novel pairing agents with lower toxicity, integration of multidimensional LC workflows, greener volatile counterions, and enhanced high-resolution MS platforms. Automated method development algorithms could expedite reagent screening, and routine applications may target larger constructs such as long RNAs and conjugated oligonucleotides.
The study demonstrates that careful selection of ion-pairing amines and counterions, coupled with gradient optimization, yields significant gains in chromatographic performance and MS sensitivity for oligonucleotide analysis, offering cost and quality advantages over traditional formulations.
HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Summary
Significance of the Topic
The reliable analysis of synthetic oligonucleotides underpins the development, quality assurance, and therapeutic application of modern nucleic acid drugs. Ion-pair liquid chromatography coupled with UV or mass spectrometric detection is widely used to separate and characterize oligonucleotide products, identify process-related impurities, and support sequence confirmation. Optimizing mobile phase additives enhances separation efficiency, detection sensitivity, and reduces analysis cost.
Objectives and Study Overview
This work evaluates the impact of various ion-pairing reagents—triethylamine, n-butylamine, dibutylamine, and hexylamine—combined with acetate or hexafluoroisopropanol (HFIP) counterions on reversed-phase LC/UV and LC/MS performance for oligonucleotides. Chromatographic retention, resolution, mass spectral quality, charge-state distribution, and adduct formation were compared using DNA and RNA ladder standards as well as therapeutic oligonucleotides.
Methodology and Instrumentation
Experimental conditions included an Agilent AdvanceBio oligonucleotide column (2.1×50 mm, 2.7 µm) on an Agilent 1290 Infinity II LC system with diode-array detection and an Agilent 6530 LC/Q-TOF MS with Jet Stream ESI. Mobile phases comprised equimolar amine/acetic acid buffers (100 mM) or mixtures of 15 mM amine with HFIP (25–400 mM) in water, eluted with shallow gradients of acetonitrile or methanol at 65 °C.
Main Results and Discussion
- Amine-acetate buffers: Hexylamine and dibutylamine improved retention and peak resolution relative to triethylamine for both DNA and RNA standards under LC/UV detection.
- HFIP-based phases: Combining triethylamine with HFIP dramatically increased MS sensitivity and shifted charge envelopes to higher states, facilitating cleaner spectra.
- HFIP concentration: Lowering HFIP from 400 mM to 25–100 mM maintained or improved chromatographic resolution while reducing reagent cost and adduct formation.
- Therapeutic samples: Alternative mobile phases enhanced separation of sense/antisense strands, reduced co-elution of shortmers, and improved mass spectral clarity.
Benefits and Practical Applications
Optimized ion-pair reagent selection allows tailored separations for diverse oligonucleotide chemistries, improves impurity resolution, and boosts MS detection while lowering consumable usage. Reduced adduct formation enhances confidence in mass assignments, supporting robust sequence verification and impurity profiling in QA/QC and research environments.
Future Trends and Opportunities
Advances may include novel pairing agents with lower toxicity, integration of multidimensional LC workflows, greener volatile counterions, and enhanced high-resolution MS platforms. Automated method development algorithms could expedite reagent screening, and routine applications may target larger constructs such as long RNAs and conjugated oligonucleotides.
Conclusion
The study demonstrates that careful selection of ion-pairing amines and counterions, coupled with gradient optimization, yields significant gains in chromatographic performance and MS sensitivity for oligonucleotide analysis, offering cost and quality advantages over traditional formulations.
References
- Goyon A; Yehl P; Zhang K. Characterization of Therapeutic Oligonucleotides by Liquid Chromatography. J Pharm Biomed Anal. 2020;182:113105.
- Vanhinsbergh CJ. Analytical Separation Methods for Therapeutic Oligonucleotides. LC-GC Chromatogr Online. 2020;33(10):20–26.
- Li Q et al. Comprehensive HILIC and Ion-Pair Reversed-Phase LC for Di- to Deca-Oligonucleotides. J Chromatogr A. 2012;1255:237–243.
- Krieger S; Dickhut C. Direct Analysis of In-Process Oligonucleotides Without Manual Purification. Agilent Technologies Application Note. 2018.
- Apffel A et al. Analysis of Oligonucleotides by HPLC-ESI-MS. Anal Chem. 1997;69:1320–1325.
- Apffel A et al. New Procedure for HPLC-ESI-MS Analysis of Nucleotides and Oligonucleotides. J Chromatogr A. 1997;777:3–21.
- Gilar M et al. Ion-Pair Reversed-Phase HPLC Analysis of Oligonucleotides: Retention Prediction. J Chromatogr A. 2002;958(1–2):167–182.
- McGinnis AC; Grubb EC; Bartlett MG. Optimization of Ion-Pairing Agents and HFIP for Enhanced ESI-MS of Oligonucleotides. Rapid Commun Mass Spectrom. 2013;27(23):2655–2664.
- Gong L; McCullagh JSO. Comparing Ion-Pairing Reagents and Dissolution Solvents for Ion-Pair Reversed-Phase LC/ESI-MS of Oligonucleotides. Rapid Commun Mass Spectrom. 2014;28(4):339–350.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
AdvanceBio Your Oligonucleotide Workflow
2023|Agilent Technologies|Brochures and specifications
AdvanceBio Your Oligonucleotide Workflow From analytical to preparative scale, Agilent AdvanceBio Oligonucleotide columns, software, and instrumentation pair seamlessly to minimize method optimization and downtime. 2 Advance Your Separations with Agilent AdvanceBio Oligonucleotide Workflow Separations Whether you are using LC/MS or…
Key words
oligonucleotide, oligonucleotideadvancebio, advancebioyour, youroligonucleotides, oligonucleotidesmin, mincps, cpsrna, rnapairing, pairinghfip, hfipagilent, agilentpreparative, preparativepurification, purificationworkflow, workflowdba, dbacounts
Agilent AdvanceBio Oligonucleotide Columns and Oligonucleotide Standards
2015|Agilent Technologies|Brochures and specifications
Agilent AdvanceBio Oligonucleotide Columns and Oligonucleotide Standards IMPROVE RELIABILITY. REDUCE COSTS. INCREASE FLEXIBILITY. AGILENT ADVANCEBIO OLIGONUCLEOTIDE COLUMNS AND OLIGONUCLEOTIDE STANDARDS HIGH-RESOLUTION OLIGONUCLEOTIDE SEPARATIONS WITH LONG COLUMN LIFETIME ON HPLC AND UHPLC SYSTEMS Synthetic oligonucleotides are promising therapeutic agents for the…
Key words
oligonucleotide, oligonucleotideadvancebio, advancebioseparations, separationsagilent, agilentmau, mauoligonucleotides, oligonucleotidesoligo, oligotriethylammonium, triethylammoniumlifetime, lifetimerna, rnacolumns, columnsteaa, teaahexafluoroisopropanol, hexafluoroisopropanoldna, dnaresolution
Thermo Scientific DNAPac Family of Columns
2022|Thermo Fisher Scientific|Brochures and specifications
Thermo Scientific DNAPac Family of Columns Superior Oligonucleotide Analysis DNAPac RP 2016 DNAPac PA200 RS 2013 DNASwift SAX-1S 2009 For over 30 years, the Thermo Scientific™ DNAPac™ family of columns has been the go-to for high resolution U/HPLC separation of…
Key words
dnapac, dnapacoligonucleotide, oligonucleotidemin, minabsorbance, absorbancetime, timephosphothioate, phosphothioatelength, lengthformat, formatdiastereoisomers, diastereoisomersphosphorothioated, phosphorothioatedrna, rnadnaswift, dnaswiftcolumn, columnoligonucleotides, oligonucleotidesparticle
Oligonucleotide Analysis: Practical Techniques and Method Development Optimization for HPLC
2023|Agilent Technologies|Presentations
Oligonucleotide Analysis: Practical Techniques and Method Development Optimization for HPLC Mohit Patel LC Columns and Consumables Technical Support December 19, 2023 1 12/19/2023 DE # DE48216954 What Are Oligonucleotide Therapeutic Types? Oligonucleotides are being increasingly developed as therapeutics against a…
Key words
oligonucleotide, oligonucleotideoligonucleotides, oligonucleotidesadvancebio, advancebiopair, pairladder, ladderbuffer, bufferresolution, resolutionmau, maurcrarcrurgrararurarcrcrararu, rcrarcrurgrararurarcrcrararurgrurcrarurcrarcrarcrurgrararurarcrcrararu, rgrurcrarurcrarcrarcrurgrararurarcrcrararururcrarcrarcrurgrararurarcrcrararu, rurcrarcrarcrurgrararurarcrcrararururcrarurcrarcrarcrurgrararurarcrcrararu, rurcrarurcrarcrarcrurgrararurarcrcrararuion, ionphase, phasebinding